LAG3 and head and neck cancer: Some checkpoints, such as the co-inhibitory checkpoint and marker for immune exhaustion lymphocyte-activation gene 3 (LAG-3), are associated with clinical characteristics and disease outcomes such as in advanced head and neck cancer (10).